| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/23/1999 | CN1220270A Improved process for stabilizing proteins |
| 06/23/1999 | CN1043786C Method for preparing antibiotic compound |
| 06/23/1999 | CA2222770A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/22/1999 | US5914252 Polype(tide found on the surface of synovial cells from patients with rheumatoid arthritis; for diagnostic reagents |
| 06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914123 Food comprising transgenic plant material, ingestible for nutritional value, expressing recombinant immunogen derived from hepatitis virus |
| 06/22/1999 | US5914114 Concensus peptide and amino acid sequences thereof; conjugated to a molecule that increases antigenicity; immunizing mammals against varying strains of enterotoxigenic escherichia coli; colonization factor antigens (cfa) |
| 06/22/1999 | US5914113 Inactivated immunogens from avian pathogens, an adjuvant and a live chicken anemia virus |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5914095 Polychelants containg amide bonds |
| 06/22/1999 | CA1340603C Tri-aza macrocycles and metal complexes thereof |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999029883A2 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease |
| 06/17/1999 | WO1999029872A1 Nucleic acid molecules encoding canine parainfluenza type 2f and hn proteins |
| 06/17/1999 | WO1999029871A2 Circovirus sequences related to piglet weight loss disease (pwd) |
| 06/17/1999 | WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/17/1999 | WO1999029869A1 Compounds and methods for the diagnosis and treatment of b. microti infection |
| 06/17/1999 | WO1999029867A1 Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease |
| 06/17/1999 | WO1999029865A2 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof |
| 06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | WO1999029852A1 High-affinity tryptophan transporter |
| 06/17/1999 | WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 06/17/1999 | WO1999029728A1 Method and composition to enhance the efficacy of a vaccine using chemokines |
| 06/17/1999 | WO1999029724A2 Dna encoding pasteurella multocida outer membrane protein |
| 06/17/1999 | WO1999029723A1 Recombinant nodavirus compositions and methods |
| 06/17/1999 | WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
| 06/17/1999 | WO1999029721A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/17/1999 | WO1999029344A1 Product and process for targeting an immune response |
| 06/17/1999 | WO1999029343A1 Method of treating bladder cancer with wild type vaccinia virus |
| 06/17/1999 | WO1999029342A1 Vaccines containing attenuated bacteria |
| 06/17/1999 | WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides |
| 06/17/1999 | WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 06/17/1999 | WO1999029310A2 Regulation of t cell-mediated immunity by tryptophan and its analogs |
| 06/17/1999 | WO1999018216A3 Chimeric vaccine against tick-borne encephalitis virus |
| 06/17/1999 | WO1999017801A3 Materials and methods relating to the stimulation of cells |
| 06/17/1999 | WO1999017796A3 Modulation of lerk-2-mediated cell adhesion |
| 06/17/1999 | WO1999016426A3 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 06/17/1999 | WO1999015198A3 Agents for combating bacterial meningitis |
| 06/17/1999 | WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/17/1999 | WO1999004237A3 Diagnosis of spongiform encephalopathies using prionins |
| 06/17/1999 | WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/17/1999 | CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/17/1999 | CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 06/17/1999 | CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4 |
| 06/17/1999 | CA2314267A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2314006A1 Method and composition to enhance the efficacy of a vaccine using chemokines |
| 06/17/1999 | CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/17/1999 | CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/17/1999 | CA2313703A1 Vaccines containing attenuated bacteria |
| 06/17/1999 | CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | CA2311681A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | CA2256250A1 Method for enhancing an immune response using mitogenic and chemokinetic factors |
| 06/16/1999 | EP0922762A1 Drug binding protein |
| 06/16/1999 | EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922103A1 NEW $i(BRUCELLA) ANTIGENS, RECOMBINANT POLYPEPTIDES, NUCLEIC ACIDS CODING FOR THE SAME AND USE THEREOF IN DIAGNOSTIC AND PROPHYLACTIC METHODS AND KITS |
| 06/16/1999 | EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 06/16/1999 | EP0922092A1 Method of attenuating viruses |
| 06/16/1999 | EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/16/1999 | EP0922057A1 Myelin oligodendrocyte glycoprotein peptides and uses thereof |
| 06/16/1999 | EP0922056A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 06/16/1999 | EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
| 06/16/1999 | EP0921855A1 Isolation of immunoglobulins |
| 06/16/1999 | EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 06/16/1999 | EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921813A1 Immunogenic preparation and method for improving the productivity of ruminant animals |
| 06/16/1999 | EP0921811A2 Administration of histamine for therapeutic purposes |
| 06/16/1999 | EP0921805A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 06/16/1999 | EP0669976B1 Screening method using transcription factor DP-1 |
| 06/16/1999 | EP0640128B1 Attenuated respiratory syncytial virus vaccine compositions |
| 06/16/1999 | EP0491828B1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 06/16/1999 | CN1219969A Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/16/1999 | CN1219968A Antibodies to ED-8 domain of fibronectin, their construction and uses |
| 06/16/1999 | CN1219967A Glial cell line-derived neurotrophic factor receptor |
| 06/16/1999 | CN1219882A Concentrated antibody preparation |
| 06/16/1999 | CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection |
| 06/15/1999 | US5912337 Parasitic helminth p22U proteins |
| 06/15/1999 | US5912336 Dna molecule coding for an iron-controlled protein found in gram-negative bacteria outer membranes; treatment of gonorrhea and meninigitis |
| 06/15/1999 | US5912334 DNA encoding equine interleukin-1 |
| 06/15/1999 | US5912325 A polypeptide which codes for an epitope of an animal growth hormone; animal growth enhancer |
| 06/15/1999 | US5912166 Compounds and methods for diagnosis of leishmaniasis |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912143 Polynucleotides encoding a human mage protein homolog |
| 06/15/1999 | US5912122 A polynucleotide coding for a central nervous system g protein receptor; therapy for neurodegenerative disorders |
| 06/15/1999 | US5912000 Chitosan induced immunopotentiation |
| 06/15/1999 | US5911999 Vaccine based on TGEV for protection of dogs against canine coronavirus |
| 06/15/1999 | US5911998 Inoculating cultures(which are free of adventitious microbial agents) with desired virus, then incubation and harvesting virus for use in vaccine |
| 06/15/1999 | US5911996 Fusion proteins from actinobacillus, soluble on sodium lauryl sarcosinate derived by genetic engineering for immunity |
| 06/15/1999 | US5911991 Malarial binding site in duffy blood group protein |
| 06/15/1999 | US5911989 Antibodies |
| 06/15/1999 | US5911987 Cell surface protein and effector cell bonding reagent |
| 06/15/1999 | CA2137363C Use of zona pellucida glycoproteins for immunocontraception |
| 06/15/1999 | CA2088068C Protein structure of the plant toxin gelonin |